RECRUITING

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about quality of life in patients who have or have had rectal cancer.

Official Title

Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer

Quick Facts

Study Start:2014-05-16
Study Completion:2025-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02107105

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient has histologically proven adenocarcinoma of the rectum (stage I - IV) that is planned to be treated by surgical resection performed with curative intent, or who has already received surgical treatment
  2. * Patient must sign an approved informed consent document and have the literary and physical ability to complete the questionnaire in English
  1. * Patient has been treated with pelvic radiation therapy for a diagnosis other than rectal cancer
  2. * Patient has a concurrent cancer diagnosis at the time of consent
  3. * Patient has recurrent disease

Contacts and Locations

Study Contact

George Chang
CONTACT
713-792-6940
GChang@mdanderson.org

Principal Investigator

George J Chang
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • George J Chang, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-05-16
Study Completion Date2025-05-31

Study Record Updates

Study Start Date2014-05-16
Study Completion Date2025-05-31

Terms related to this study

Additional Relevant MeSH Terms

  • Rectal Adenocarcinoma
  • Stage I Rectal Cancer AJCC V8
  • Stage II Rectal Cancer AJCC V8
  • Stage IIA Rectal Cancer AJCC V8
  • Stage IIB Rectal Cancer AJCC V8
  • Stage IIC Rectal Cancer AJCC V8
  • Stage III Rectal Cancer AJCC V8
  • Stage IIIA Rectal Cancer AJCC V8
  • Stage IIIB Rectal Cancer AJCC V8
  • Stage IIIC Rectal Cancer AJCC V8
  • Stage IV Rectal Cancer AJCC V8
  • Stage IVA Rectal Cancer AJCC V8
  • Stage IVB Rectal Cancer AJCC V8
  • Stage IVC Rectal Cancer AJCC V8